GO:0019477 L-lysine catabolic process

L-lysine is an essential amino acid that serves as a building block for proteins and as a precursor for numerous primary and secondary metabolites. The Gene Ontology term GO:0019477, L-lysine catabolic process, defines the set of biochemical reactions that result in the breakdown of L-lysine into simpler molecules. This process is fundamental to cellular nitrogen and carbon balance, and it is conserved across bacteria, plants, and animals, though the specific enzymes and intermediates vary by organism [1, 6]. Understanding L-lysine catabolism is critical for both basic biology and applied biotechnology, as it intersects with amino acid fermentation, immune signaling, and metabolic disease [1, 3, 6]. In industrial microbiology, L-lysine catabolism is studied in the context of fermentation processes, where Corynebacterium glutamicum and related species are engineered to overproduce or degrade lysine for the production of feed additives and other value-added compounds [1, 5]. The catabolic pathways in these bacteria are tightly regulated to balance lysine biosynthesis and degradation, and they are targets for metabolic engineering [5, 8]. In plants, L-lysine catabolism leads to the formation of N-hydroxypipecolic acid, a mobile signal that activates systemic acquired resistance against pathogens. This illustrates how a core metabolic pathway can be co-opted for immune functions. In mammals, L-lysine catabolism occurs primarily in the liver and kidney, and its dysregulation has been linked to diabetic nephropathy and other metabolic complications. Recent studies have also revealed that gut bacterial L-lysine catabolism influences host immune tolerance by modulating histone methylation in dendritic cells. These findings highlight the broad physiological relevance of GO:0019477 and the need for precise experimental models to dissect its components. This article provides a research-grade overview of the L-lysine catabolic process, its key genes, regulatory mechanisms, disease connections, and the CRISPR-based methods used to study it.

The L-lysine catabolic process (GO:0019477) encompasses all chemical reactions and pathways that result in the breakdown of L-lysine, an essential amino acid. This includes the enzymatic conversion of L-lysine into intermediates such as saccharopine, pipecolic acid, and acetyl-CoA, ultimately yielding energy and smaller metabolites [1, 6]. The process is distinct from L-lysine biosynthesis and is often regulated in response to cellular energy status and nitrogen availability.

L-lysine catabolism is important because it controls the availability of a key amino acid for protein synthesis, provides precursors for secondary metabolites, and influences immune and metabolic signaling. In industrial biotechnology, manipulating this pathway enhances lysine production or conversion to valuable compounds [1, 5]. In plants, it generates immune-activating molecules. In humans, its dysregulation contributes to diabetic nephropathy and immune tolerance, making it a potential therapeutic target [3, 7].

The following genes and proteins are experimentally implicated in L-lysine catabolic process across model organisms.

L-lysine catabolism is regulated at multiple levels. In bacteria such as Corynebacterium glutamicum, the expression of catabolic genes is controlled by nitrogen-responsive regulators and feedback inhibition by lysine. In plants, the pipecolic acid pathway is induced upon pathogen infection and is regulated by salicylic acid signaling. In mammals, the saccharopine pathway is regulated by nutritional status, with fasting and high-protein diets increasing flux through the pathway. Additionally, gut bacterial L-lysine catabolism is influenced by the host immune environment and can modulate histone methylation in dendritic cells.

Dysregulation of L-lysine catabolism has been observed in diabetic nephropathy. In a rat model of streptozotocin-induced diabetes, L-lysine supplementation ameliorated kidney damage, suggesting that modulating lysine catabolism may be therapeutic. The mechanism may involve reduced oxidative stress and inflammation.

Mutations in AASS, which encodes a key enzyme in the saccharopine pathway, cause hyperlysinemia, a rare metabolic disorder characterized by elevated lysine levels and neurological symptoms. Similarly, deficiencies in ALDH7A1 and DHTKD1, which are involved in lysine catabolism, lead to pyridoxine-dependent epilepsy and Charcot-Marie-Tooth disease, respectively.

Gut bacterial L-lysine catabolism produces metabolites that alter host metabolism and histone methylation, driving dendritic cell tolerance. This highlights a role for L-lysine catabolism in shaping immune responses and potentially in autoimmune diseases.

In plants, L-lysine catabolism to N-hydroxypipecolic acid is an integral immune-activating pathway. Disruption of this pathway compromises systemic acquired resistance, demonstrating its importance in plant defense.

RNA-seq and microarray can quantify expression of L-lysine catabolic genes under different conditions. In Corynebacterium glutamicum, transcriptomics has revealed nitrogen-regulated expression of catabolic genes. In plants, RNA-seq has identified pathogen-induced expression of pipecolic acid pathway genes.

Metabolomics using LC-MS or GC-MS can measure intermediates such as saccharopine, pipecolic acid, and alpha-aminoadipate. Flux analysis with labeled isotopes can trace carbon flow through the pathway. These methods are essential for understanding pathway dynamics.

In vitro enzyme assays using recombinant proteins can measure the activity of lysine-ketoglutarate reductase, saccharopine dehydrogenase, and pipecolate oxidase. These assays help validate the functional impact of mutations.

CRISPR knockout libraries can be used to identify genes required for L-lysine catabolism. In C. glutamicum, CRISPR/dCas9-assisted systems have been used to co-produce lysine and heterologous squalene, demonstrating the power of CRISPR for pathway engineering.

Researchers studying L-lysine catabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease, or metabolic engineering. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such studies.

The L-lysine catabolic process (GO:0019477) is a fundamental metabolic pathway with broad implications in microbiology, plant immunity, and human health. Its dysregulation contributes to metabolic and neurological diseases, while its manipulation enables industrial production of valuable compounds. CRISPR-based tools now allow precise interrogation of this pathway, from single-gene knockouts to genome-wide screens. Continued research into L-lysine catabolism will likely reveal new therapeutic targets and biotechnological applications.